Article

Molecular docking of substituted pyrazolone analogs targeting MAO-B as therapeutic site for Parkinson: an in-silico study

2022-03-16

Abstract excerpt

Parkinson’s disease is considered as common age-related progressive neuronal disorder characterized by motor, sensory, and cognitive dysfunction. Current medication for PD offers only symptomatic relief but no cure. Although it is considered that these medicines can produce acute or chronic side effects, and becomes less effective over a time. Owing to this concerns, the discovery of novel molecule is of considera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f24af1e9-c194-5514-bf7b-9d611ccb6ba6
DOI: 10.21203/rs.3.rs-1437749/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular docking of substituted pyrazolone analogs targeting MAO-B as therapeutic site for Parkinson: an in-silico studyDOI 10.21203/rs.3.rs-1437749/v1Read

Monoamine Oxidase Inhibitors in Drug Discovery Against Parkinson’s Disease: A Brief ReviewSemantic proximity Read

Quantitative Structure-Activity Relationship (QSAR) Studies for the Inhibition of MAOs.Semantic proximity Read

Comparative Computational Docking Analysis of MPP+ and Dopamine Binding to Dopamine Transporter in Human and Zebrafish: Mechanistic Insights into MPTP NeurotoxicitySemantic proximity Read

Spondias mombin flavonoids showed super-binder ability with Downstream Molecular Targets of Parkinson’s Disease: Folkloric-therapy assessment as a Scaffold for Structural Studies in Neurodegenerative diseaseSemantic proximity Read

Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer’s disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitorsSemantic proximity Read

Computational study of human tyrosine hydroxylase mutants to uphold [4-(Propan-2-yl) Phenyl]Carbamic acid as a potential inhibitor.Semantic proximity Read

Molecular insight into the mechanism of action of some beneficial flavonoids for the treatment of Parkinson’s DiseaseSemantic proximity Read

Donepezil-based rational design of N -substituted quinazolinthioacetamide candidates as potential acetylcholine esterase inhibitors for the treatment of Alzheimer's disease: in vitro and in vivo studiesSemantic proximity Read

KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson’s diseaseSemantic proximity Read

In silico analysis of SOD1 aggregation inhibition modes of tertiary amine pyrazolone and pyrano coumarin ferulate as ALS drug candidates.Semantic proximity Read

Therapeutic potential of methylxanthine drug on alpha synuclein protein in Parkinson’s diseaseSemantic proximity Read

Bioavailability and Neuroprotectivity of 3-(3, 4-dimethoxy phenyl)-1-4 (methoxy phenyl) prop-2-en-1-one against Schizophrenia: an in silico approach.Semantic proximity Read